Delenex Therapeutics AG | VCINVEST DATA

Website

http://www.delenex.com

Industry

2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products

VCID: 349611

Profile

Corporate information

Registration country

Investment activity status

Active investor

Funding

Funding rounds

Series A

(1 May 2011)

Investor		Profile	Country	Notes
	Novo A/S		Denmark

Series A

(1 Nov 2010)

Investor		Profile	Country	Notes
	SV Life Sciences Advisers Inc		United States

Series A

(1 Nov 2010)

Investor		Profile	Country	Notes
	HBM BioVentures AG		Switzerland

Series A

(1 Nov 2010)

Investor		Profile	Country	Notes
	VI Partners AG		Switzerland

N/A

Investor		Profile	Country	Notes
	Hatteras Venture Partners II		United States

N/A

Investor		Profile	Country	Notes
	Clarus Ventures LLC	Life sciences venture capital firm	United States

Cap Table

Current and past shareholders

Investor		Contacts	Round
	Clarus Ventures LLC Life sciences venture capital firm	+1 (617) 949-2200	N/A
	Hatteras Venture Partners II	+1 (919) 484-0730	N/A
	HBM BioVentures AG	+41 (41) 768-1108	Series A
	Novo A/S		Series A
	SV Life Sciences Advisers Inc	+1 (617) 367-8100	Series A
	VI Partners AG	+41 (41) 729-0000	Series A